At Axtria Ignite, experts explored how culture, training, and strategy create competitive advantage in an increasingly commodified AI world.
The FDA has named Dexcom as the first company to take part in its TEMPO pilot, which aims to bring digital health tech to patients more quickly.
Precision Neuroscience has shown that people can control electronic devices with thought alone, without a need for electrodes implanted in the brain.
BMS and NVIDIA say their new AI alliance will deliver the life science industry's most powerful centralised AI supercomputer.
This week's round-up of private financings in the biotech arena features AdvanCell, alongside Draig, Drug Farm, MindRank AI, and Alchemab.
Editor's Picks
